SCHEMBL4474912

SCHEMBL4474912

CC(=O)Oc1cccc2cc(S(=O)(=O)Cl)ccc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.45
POLB P06746 4/20 0.45
ALDH1A1 P00352 4/20 0.45
TDP1 Q9NUW8 3/20 0.45
GAA P10253 2/20 0.45
MAPT P10636 2/20 0.45
KDM4E B2RXH2 2/20 0.45
BLM P54132 2/20 0.45
APEX1 P27695 1/20 0.45
RECQL P46063 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
CASP6 P55212 1/20 0.44
MEN1 O00255 3/20 0.40
MAPK1 P28482 2/20 0.40
PTGS1 P23219 2/20 0.40
HSD17B10 Q99714 2/20 0.40
PGR P06401 1/20 0.40
FABP7 O15540 1/20 0.39
FABP3 P05413 1/20 0.39
FABP5 Q01469 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7820963 0.87 CASP6 (0.58) KMT2APOLBALDH1A1TDP1GAA
SCHEMBL13675023 0.87 KMT2A (0.46) KMT2APOLBALDH1A1TDP1GAA
SCHEMBL8690346 0.84 HTT (0.47) KMT2APOLBALDH1A1TDP1GAA
SCHEMBL4480492 0.79 CYP2C9 (0.53) KMT2AALDH1A1GAARECQLMEN1
SCHEMBL9787566 0.79 CA12 (0.46) KMT2APOLBALDH1A1TDP1GAA
SCHEMBL8693647 0.77 KMT2A (0.49) KMT2APOLBALDH1A1TDP1GAA
SCHEMBL9476254 0.77 KDM4E (0.50) KMT2APOLBALDH1A1TDP1GAA
SCHEMBL26036680 0.77 MAOB (0.50) KMT2APOLBALDH1A1TDP1GAA
SCHEMBL9299723 0.77 TSHR (0.51) KMT2APOLBALDH1A1GAAMAPT
SCHEMBL19355167 0.77 ALDH1A1 (0.49) KMT2APOLBALDH1A1TDP1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7598418-B2 Naphthalene-1-(sulfonamide or carboxamide) derivatives; e.g. N-Benzyl-5-{[(4-methylphenyl)sulfonyl]oxy}naphthalene-1-sulfonamide; protein kinase inhibitors sensitize cancer cells to radiotherapy or anticancer agents; side effect reduction INSTITUTE OF MEDICINAL MOLECULAR DESIGN, INC. (JP) 2009-10-06 US disclosed
US-7598418-B2 Naphthalene-1-(sulfonamide or carboxamide) derivatives; e.g. N-Benzyl-5-{[(4-methylphenyl)sulfonyl]oxy}naphthalene-1-sulfonamide; protein kinase inhibitors sensitize cancer cells to radiotherapy or anticancer agents; side effect reduction INSTITUTE OF MEDICINAL MOLECULAR DESIGN, INC. (JP) 2009-10-06 US disclosed
US-20050215645-A1 Amide derivatives INSTITUTE OF MEDICINAL MOLECULAR DESIGN. INC. (JP) 2005-09-29 US disclosed
US-5707985-A Naphthyl-, quinolyl- and isoquinolyl- sulfonamide derivatives as cell adhesion modulators TANABE SEIYAKU CO. LTD. (JP) 1998-01-13 US disclosed
WO-1996040641-A1 SULFONAMIDE DERIVATIVES AS CELL ADHESION MODULATORS TANABE SEIYAKU CO., LTD. (JP) 1996-12-19 WO disclosed
EP-0150319-B1 COLOUR-PHOTOGRAPHIC RECORDING MATERIAL WITH A BLUE-GREEN DYE RELEASING COMPOUND, THE COLOUR IMAGE OBTAINED BY MEANS OF THIS DYE AND THE DYE ITSELF Agfa-Gevaert AG (DE) 1987-07-01 EP disclosed
EP-0132577-B1 COLOUR-PHOTOGRAPHIC RECORDING MATERIAL WITH A DYE RELEASER FOR BLUE-GREEN DYESTUFFS, A COLOUR IMAGE OBTAINED WITH THESE DYESTUFFS AND THE DYESTUFFS THEMSELVES Agfa-Gevaert AG (DE) 1986-11-26 EP disclosed
US-4579805-A DIFFUSION TRANSFER AGFA-GEVAERT AKTIENGESELLSCHAFT (DE) 1986-04-01 US disclosed
EP-0150319-A2 Colour-photographic recording material with a blue-green dye releasing compound, the colour image obtained by means of this dye and the dye itself Agfa-Gevaert AG (DE) 1985-08-07 EP disclosed
US-4524124-A PHOTOSTABLE CYAN IMAGE DYES FOR DYE DIFFUSION TRANSFER AGFA-GEVAERT AKTIENGESELLSCHAFT (DE) 1985-06-18 US disclosed
EP-0132577-A1 Colour-photographic recording material with a dye releaser for blue-green dyestuffs, a colour image obtained with these dyestuffs and the dyestuffs themselves Agfa-Gevaert AG (DE) 1985-02-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050215645-A1 Amide derivatives OGG1, HDAC1, BCL2A1 KMT2A 1012/4885POLB 296/4885ALDH1A1 1461/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.